跳至主要內容

4月出口貨值按年升1.1%

政府統計處公布,4月本港整體出口貨值按年上升1.1%,進口貨值也升2.1%,錄得有形貿易逆差366億元,相等於商品進口貨值的8.6%。   4月商品整體出口貨值為3,890億元,進口貨值為4,256億元。   經季節性調整的數字顯示,截至4月止的三個月與對上三個月比較,商品整體出口貨值下跌12%,進口貨值也跌11.7%。   政府表示,由疫情引致的運輸干擾在4月較後時間稍為紓緩,但仍繼續約束出口表現。輸往內地的出口下跌,輸往美國和歐盟的出口則錄得顯著增長。   展望未來,部分主要經濟體通脹嚴重,相關央行因而收緊貨幣政策,加上烏克蘭局勢緊張,以及疫情的威脅持續,環球經濟前景轉差,將會繼續影響本港短期出口表現。不過,本地疫情穩定應有利於跨境陸路運輸逐步恢復,緩解對外貿易的部分壓力。
http://dlvr.it/SR8JVZ

此網誌的熱門文章

香港 Backlinks 網站, 中文本地 SEO 必備

市面上的 Backlinks 多數來自外國英文網站,對於香港網站未能精準地改善中文版 Google 排名,有見及此,有 IT 公司推出為香港公司而設的繁體中文 Backlinks 服務,在 100 多個高誠信度的新聞網站刊登文案,增加香港 Backlinks ,大大提升中文版 Google 排名。 新聞網站包括: https://www.buyinghongkong.com https://www.eatinghongkong.com https://www.playinghongkong.com https://www.relaxhongkong.com https://www.hk-bfn.com https://www.hk-cln.com https://www.hk-swn.com https://www.biznews.org.hk https://www.building.org.hk https://www.citylife.org.hk https://www.educate.org.hk https://www.healthy.org.hk https://www.hongkong.org.hk https://www.lohas.org.hk https://www.funding.org.hk https://www.tvp.org.hk https://www.bud.org.hk https://www.smefund.org.hk https://news.business138.com https://news.corporate138.com https://news.company138.com https://news.product138.com https://news.service138.com https://news.solution138.com https://news.website138.com https://news.supplier138.com https://news.vendor138.com https://news.directory138.com https://news.business228.com https:

Hong Kong Science Park: Healthy ecosystem cultivates powerful global collaboration

(English) A healthy ecosystem cultivates powerful global collaboration   BeiGene, a global commercial-stage biotech company, has entered a worldwide strategic collaboration with our park company InnoRNA to take mRNA-based therapeutics to the next level. bit.ly/3yW8S0f You probably heard about Messenger RNA (mRNA). It has been used in some of the leading COVID vaccines. Q: What's mRNA's superpower? A: It directs human cells to generate proteins to help our immune systems develop antibodies for disease prevention and treatment. Q: What's InnoRNA's superpower? A: The platform developed by CEO Dr Li Linxian makes the mRNA less fragile, and the technology can rapidly and accurately identify safe and effective mRNA carriers for clinical treatment. Q: What's HKSTP's superpower? A: Hong Kong is the world's number two biotech funding hub.  We will leave you to find out more! Follow our page for more biotech news in Hong Kong and beyond. Reference : ht

HKSTP Park Company Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform

Congratulations! Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform and the lentiviral vector production system developed by their team based at our Park.   Millions of people globally are suffering from different type of cancers. Our park company, Eurekabio, specialises in manufacturing supplies and platform for Cell and Gene Therapies (CGT).   Thank you Eurekabio for playing a pivotal role in accelerating the development of CGT through automation - Standardising cell processing procedures - Increasing efficiency - Reducing human error and contamination   Learn more: https://lnkd.in/gEGmc7Vz   Follow our page for more fundraising news happening in our thriving ecosystem. More Information : https://www.hkstp.org/what-we-offer/institute-for-translational-research-overview/